Repligen
RGEN
#2620
Rank
โ‚น625.51 B
Marketcap
โ‚น11,091
Share price
-0.31%
Change (1 day)
3.81%
Change (1 year)
Categories

Revenue for Repligen (RGEN)

Revenue in 2025 (TTM): โ‚น64.63 Billion

According to Repligen 's latest financial reports the company's current revenue (TTM ) is โ‚น68.56 Billion. an increase over the revenue in the year 2024 that were of โ‚น54.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Repligen from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น66.27 B21.77%
2024 โ‚น54.42 B5.2%
2023 โ‚น51.73 B-22%
2022 โ‚น66.32 B32.9%
2021 โ‚น49.90 B86.32%
2020 โ‚น26.78 B38.99%
2019 โ‚น19.27 B42.04%
2018 โ‚น13.56 B50.44%
2017 โ‚น9.01 B26.94%
2016 โ‚น7.10 B27.97%
2015 โ‚น5.55 B37.84%
2014 โ‚น4.02 B-4.37%
2013 โ‚น4.21 B23.53%
2012 โ‚น3.40 B
2010 โ‚น1.17 B22.54%
2009 โ‚น0.96 B-28.83%
2008 โ‚น1.34 B74.55%
2007 โ‚น0.77 B31.6%
2006 โ‚น0.58 B0.24%
2005 โ‚น0.58 B59.56%
2004 โ‚น0.36 B17.77%
2003 โ‚น0.31 B-10.27%
2002 โ‚น0.34 B98.35%
2001 โ‚น0.17 B40.2%
2000 โ‚น0.12 B-16.48%
1999 โ‚น0.14 B46.61%
1998 โ‚น0.10 B-10.46%
1997 โ‚น0.11 B-16.57%
1996 โ‚น0.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น5.812 T 8,376.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.138 T 5,935.17%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น4.258 T 6,111.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.476 T 6,428.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น3.05 B-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น95.14 B 38.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น265.68 B 287.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น112.90 B 64.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น299.19 B 336.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น372.95 B 443.90%๐Ÿ‡บ๐Ÿ‡ธ USA